bluebird bio, Inc. — Form D
bluebird bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-21. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-21
- Form: D
- Accession: 0001293971-21-000070
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $75.0M
- Amount sold: $75.0M
- Investors: 2
- Date of first sale: 2021-09-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-414037
Issuer
- Name: bluebird bio, Inc.
- CIK: 0001293971
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 840 MEMORIAL DR 4th FL, CAMBRIDGE, MA, 02139
- Phone: 617-491-5601
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| John S Agwunobi | Director | Cambridge, MA |
| Wendy S Dixon | Director | Cambridge, MA |
| Ramy S Ibrahim | Director | Coral Gables, FL |
| Nick S Leschly | Director | Cambridge, MA |
| Daniel S Lynch | Director | Cambridge, MA |
| William R Sellers | Director | CAMBRIDGE, MA |
| Denice R Torres | Director | CAMBRIDGE, MA |
| Mark R Vachon | Director | Cambridge, MA |
| Chip Baird | Executive Officer | New York, NY |
| Jason Cole | Executive Officer | Cambridge, MA |
| Nick S Leschly | Executive Officer | Cambridge, MA |
| Nick Leschly | Director | Cambridge, MA |
| Nick Leschly | Executive Officer | Cambridge, MA |
| Steven Gillis | Director | South San Francisco, CA |
| James A Geraghty | Director | Lexington, MA |
| Robert Tepper | Director | Cambridge, MA |
| Geert-Jan HC Mulder | Director | Waltham, MA |
| Axel Polack | Director | Cambridge, MA |
| Geert-Jan A Mulder | Director | Cambridge, MA |
| Daniel S. Lynch | Director | Cambridge, MA |
| Jeffrey T. Walsh | Executive Officer | Cambridge, MA |
| John M. Maraganore | Director | Cambridge, MA |
Other filings by this issuer (4)
More